Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes
Shuiyan Wu, You Jiang, Yi Hong, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 163
An overview of PROTACs: a promising drug discovery paradigm
Liu Zi, Mingxing Hu, Yang Yu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 156
Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
Ailin Zhao, Hui Zhou, Jinrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
Jeremy M. Kelm, Deepti S. Pandey, Evan Malin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 51
Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 22
The Common Hallmarks of Aging, Circadian Rhythms and Cancer: Implications for Therapeutic Strategies
Jie Wang, Fanglin Shao, Qingxin Yu, et al.
Research (2025) Vol. 8
Open Access | Times Cited: 2
Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs)
Aishwarya Saraswat, Richa Vartak, Rehab Hegazy, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 1, pp. 103387-103387
Open Access | Times Cited: 39
Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach
Qiuxia Chen, Chuan Liu, Wei Wang, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 1, pp. 25-33
Open Access | Times Cited: 32
PROTACs: Novel tools for improving immunotherapy in cancer
Shizhe Li, Ting Chen, Jinxin Liu, et al.
Cancer Letters (2023) Vol. 560, pp. 216128-216128
Closed Access | Times Cited: 25
Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety
Renshuai Zhang, Songbo Xie, Jie Ran, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 10
Proteomic approaches advancing targeted protein degradation
Gajanan Sathe, Gopal P. Sapkota
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 11, pp. 786-801
Open Access | Times Cited: 22
Recent advances in epigenetic anticancer therapeutics and future perspectives
Liwen Ren, Yihui Yang, Li Wan, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 20
Cereblon-Recruiting PROTACs: Will New Drugs Have to Face Old Challenges?
Marcin Cieślak, Marta Słowianek
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 812-812
Open Access | Times Cited: 20
Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Mengyao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Functional Roles of Bromodomain Proteins in Cancer
Samuel P. Boyson, Cong Gao, Kathleen Quinn, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3606-3606
Open Access | Times Cited: 39
Phase separation in cancer at a glance
Qingqing Xie, Jiejuan Cheng, Wuxuan Mei, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Selective degradation of BRD4 suppresses lung cancer cell proliferation using GSH-responsive PROTAC precursors
Heli Fan, Zhili Zhou, Dehao Yu, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106793-106793
Closed Access | Times Cited: 15
The SCF Complex Is Essential to Maintain Genome and Chromosome Stability
Laura L. Thompson, Kailee A. Rutherford, Chloe C. Lepage, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8544-8544
Open Access | Times Cited: 32
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma
Yuan-hong Huang, Chao‐Ling Wan, Haiping Dai, et al.
Annals of Hematology (2023) Vol. 102, Iss. 8, pp. 2001-2013
Closed Access | Times Cited: 12
Insights From Protein Frustration Analysis of BRD4-Cereblon Degrader Ternary Complexes Show Separation of Strong from Weak Degraders
Tianyi Yang, Elizaveta Mukhaleva, Wenyuan Wei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Epigenetic Rewiring of Protein Kinase Signalling in T-Cell Acute Lymphoblastic Leukaemia
Claudina Pérez-Novo, Amber Driesen, Maaike Van Trimpont, et al.
Kinases and Phosphatases (2025) Vol. 3, Iss. 2, pp. 7-7
Open Access
Targeting Myc through BET-PROTAC elicits potent anti-lymphoma activity in diffuse large B cell lymphoma
Hui Wang, Ximei Wu, Jingjing Gao, et al.
Investigational New Drugs (2025)
Closed Access
ARV-825 Demonstrates Antitumor Activity in Gastric Cancer via MYC-Targets and G2M-Checkpoint Signaling Pathways
Xinmei Liao, Xiaoqing Qian, Zimu Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 26
A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells
Kunlong Zhang, Li Gao, Jianwei Wang, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 17
BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells
Su‐Lim Kim, Hack Sun Choi, Dong‐Sun Lee
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top